{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:22:32Z","timestamp":1777879352773,"version":"3.51.4"},"reference-count":57,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Drug Safety"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Vancomycin exhibits high pharmacokinetic variability, particularly in hematopoietic stem cell transplantation (HSCT) patients, where augmented renal clearance (ARC) may compromise therapeutic exposure. This variability necessitates individualized dosing strategies to ensure optimal treatment efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To evaluate the pharmacokinetic variability of vancomycin in pediatric and adult patients undergoing HSCT and to assess the association of ARC with serum drug concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We analyzed medical records of post-HSCT patients with febrile neutropenia who received intravenous vancomycin at a tertiary hospital in Lima, Peru. Vancomycin plasma concentrations were assessed at baseline and after dose adjustments. Pharmacokinetic parameters were estimated using Bayesian modeling via PrecisePK software. Regression models were used to evaluate associations between creatinine clearance and vancomycin area under the curve (AUC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 40 post-HSCT patients were included, 50% of whom were female. The median age was 17.0\u2009years (interquartile range (IQR): 12.0\u201339.5), with 25% belonging to the pediatric group. The most frequent disease was B-cell acute lymphoblastic leukemia (47.5%). A significant change was observed in the vancomycin area under the curve (AUC\n                      <jats:sub>0\u201324<\/jats:sub>\n                      \/MIC) before and after dose adjustment (343\u2009mg\u2009h\/L vs 523\u2009mg\u2009h\/L;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The median relative dose adjustment percentage of vancomycin was 45% (IQR: 20\u201373.3). In the multivariate linear regression model, an increase in creatinine clearance was associated with a lower vancomycin AUC (\u03b2\u2009=\u2009\u22120.67; 95% CI: \u22121.14 to \u22120.19). This relationship was maintained after bootstrap resampling with 3000 repetitions (\u03b2\u2009=\u2009\u22120.67; 95% CI: \u22121.11 to \u22120.23). Sepsis was associated with the development of ARC (aRR: 1.378; 95% CI: 1.164\u20131.631), and as age increased, the risk of ARC decreased (aRR: 0.991; 95% CI: 0.99\u20130.996).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Most post-HSCT patients had subtherapeutic vancomycin levels at the beginning of treatment, which were optimized through individualized adjustments. The pharmacokinetic variability associated with ARC in young patients and those with sepsis supports the use of AUC-based therapeutic drug monitoring over trough concentration monitoring. These findings also highlight the importance of early renal function monitoring in patients treated with HSCT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20420986251384239","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:13:02Z","timestamp":1761721982000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetic variability of vancomycin in patients undergoing hematopoietic stem cell transplantation: a retrospective cohort study in Peru"],"prefix":"10.1177","volume":"16","author":[{"given":"Wilder","family":"Bola\u00f1os-Vargas","sequence":"first","affiliation":[{"name":"Departamento de Farmacia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Per\u00fa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3497-0158","authenticated-orcid":false,"given":"Cesar","family":"Copaja-Corzo","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n para la Generaci\u00f3n y S\u00edntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Per\u00fa"},{"name":"Servicio de Infectologia, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Per\u00fa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Wong-Chang","sequence":"additional","affiliation":[{"name":"Departamento de Hematolog\u00eda, Servicio de Hematolog\u00eda Especializada, Hospital Nacional Edgardo Rebagliati Martins, Lima, Per\u00fa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Santamaria-Leandro","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n de Redes Integradas de Salud Lima Este (DIRIS Lima Este), Lima, Per\u00fa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liz","family":"Aliaga-Tabraj","sequence":"additional","affiliation":[{"name":"Unidad de Farmacia Cl\u00ednica, Hospital Edgardo Rebagliati Martins, Lima, Per\u00fa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Fernandez-Puycan","sequence":"additional","affiliation":[{"name":"Organic Pharmacy Unit, Cl\u00ednica Stella Maris, Lima, Per\u00fa"},{"name":"Hospital Nacional Edgardo Rebagliati Martins, Lima, Per\u00fa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo Yoshimar","family":"Luque-Mamani","sequence":"additional","affiliation":[{"name":"Departamento de Farmacia, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Per\u00fa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101214"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu006"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2019.10.005"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.874401"},{"issue":"5","key":"e_1_3_4_6_2","first-page":"525","article-title":"Influence of pharmacokinetic\/pharmacodynamic ratio on vancomycin treatment response in pediatric patients with Staphylococcus aureus bacteremia","volume":"74","author":"Ruiz J","year":"2022","unstructured":"Ruiz J, Garc\u00eda-Robles A, Marqu\u00e9s MR, et al. Influence of pharmacokinetic\/pharmacodynamic ratio on vancomycin treatment response in pediatric patients with Staphylococcus aureus bacteremia. Minerva Pediatr (Torino) 2022; 74(5): 525\u2013529.","journal-title":"Minerva Pediatr (Torino)"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa036"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030489"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-78558-1"},{"key":"e_1_3_4_10_2","article-title":"Population pharmacokinetics analyses and therapeutic drug monitoring of vancomycin: a scoping review","author":"Molina RF","year":"2024","unstructured":"Molina RF, Bandres M, Mendoza MA, et al. Population pharmacokinetics analyses and therapeutic drug monitoring of vancomycin: a scoping review. Authorea 2024. [Preprint]. Posted 9 September 2024.","journal-title":"Authorea"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13206"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14061863"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaf011"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.0021"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-04126-z"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-28797-3_6"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.782530"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082317"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0636-7"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1546465"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03147-14"},{"key":"e_1_3_4_22_2","unstructured":"EsSalud. Hospital Rebagliati de EsSalud alcanza m\u00e1xima categor\u00eda por su alta especialidad y capacidad resolutiva [Internet] https:\/\/www.essalud.gob.pe\/hospital-rebagliati-de-essalud-alcanza-maxima-categoria-por-su-alta-especialidad-y-capacidad-resolutiva\/ (2019 accessed 19 May 2025)."},{"key":"e_1_3_4_23_2","unstructured":"El Peruano. Hospital Rebagliati efectu\u00f3 m\u00e1s de 1500 trasplantes de m\u00e9dula \u00f3sea [Internet] https:\/\/elperuano.pe\/noticia\/145802-hospital-rebagliati-efectuo-mas-de-1500-trasplantes-de-medula-osea (2022 accessed 2025 May 19)."},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.04.004"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1041152"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir034"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa036"},{"key":"e_1_3_4_29_2","volume-title":"Emit\u00ae 2000 Vancomycin assay: instructions for use","author":"Beckman Coulter Inc","year":"2018","unstructured":"Beckman Coulter Inc. Emit\u00ae 2000 Vancomycin assay: instructions for use. Brea, CA: Beckman Coulter Inc., 2018."},{"key":"e_1_3_4_30_2","volume-title":"ISO 15189:2022. Medical laboratories: Requirements for quality and competence","author":"International Organization for Standardization (ISO)","year":"2022","unstructured":"International Organization for Standardization (ISO). ISO 15189:2022. Medical laboratories: Requirements for quality and competence. 4th ed. Geneva: ISO, 2022.","edition":"4"},{"key":"e_1_3_4_31_2","unstructured":"Precise PK. A leading therapeutic drug monitoring software for model-based Bayesian precision dosing [Internet] https:\/\/www.precisepk.com\/ (2025 accessed 19 May 2025)."},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.6.848"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1531"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky310"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318286378e"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.05.006"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2023.04.018"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-023-04288-4"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000002918"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.11.041"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1433417"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-024-01459-z"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.3389\/frabi.2025.1568931"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2012(07)21"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000270"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2311"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab302"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.835557"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-019-04205-x"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.12.011"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.607101"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02657-6"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.340"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b19-00652"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad079"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11070837"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1177\/08971900221121362"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05067-7"}],"container-title":["Therapeutic Advances in Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420986251384239","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20420986251384239","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420986251384239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:41:07Z","timestamp":1777592467000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20420986251384239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":57,"alternative-id":["10.1177\/20420986251384239"],"URL":"https:\/\/doi.org\/10.1177\/20420986251384239","relation":{},"ISSN":["2042-0986","2042-0994"],"issn-type":[{"value":"2042-0986","type":"print"},{"value":"2042-0994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"article-number":"20420986251384239"}}